IFNG and glycogen storage disease VI: Elevated levels of IFN-γ and STAT1 signaling are implicated in chronic lymphoid-driven human diseases, such as SLE36, 39, 42 and in mouse models of SLE, including the MRL/lpr strain39, 40.